Lymphocytic oesophagitis | Oesophageal eosinophilia (>15 eos/HPF) | OR (95% CI) (LyE vs EoE), probability | Normal oesophageal mucosa | OR (95% CI) (LyE vs normal), probability | |
Demographics | |||||
Total number | 119 | 3745 | – | 40654 | – |
Median age | 63 | 43 | p<0.001 | 55 | p<0.001 |
Men | 47 (39.5) | 2461 (65.7) | 0.34 (0.23 to 0.49), p<0.0001 | 14119 (31.6) | 1.24 (0.86 to 1.78), ns |
Clinical manifestations | |||||
Dysphagia | 63 (52.9) | 2371 (63.3) | 1.00 (0.66 to 1.51), ns | 10490 (33.0) | 4.97 (3.32 to 7.46), p<0.0001 |
GERD | 22 (18.5) | 707 (18.9) | 0.95 (0.60 to 1.52), ns | 11894 (37.4) | 0.54 (0.34 to 0.85), p<0.01 |
Suspected EoE | 37 (31.1) | 2170 (57.9) | 0.33 (0.22 to 0.49), p<0.0001 | 8379 (26.3) | 1.76 (1.20 to 2.59), p<0.01 |
Concurrent pathology | |||||
Helicobacter pylori gastritis (n=79) | 7 (8.9) | 100 (4.7) | 2.16 (1.02 to 4.92), p<0.05 | 2330 (7.3) | 1.01 (0.47 to 2.17), ns |
Coeliac disease (n=39) | 3 (7.7) | 10 (1.0) | 9.50 (2.57 to 34.9), p<0.01 | 179 (1.1) | 5.75 (1.81 to 18.2), p<0.001 |
Duodenal lymphocytosis | 2 (5.1) | 24 (2.3) | 2.60 (0.61 to 11.5), ns | 451 (3.0) | 1.49 (0.36 to 6.04), ns |
Crohn's disease | 0 | 5 (0.2) | – | 31 (0.5) | – |
EoE, eosinophilic oesophagitis; eos, eosinophils; GERD, gastro-oesophageal reflux disease; HPF, high-power field; LyE, lymphocytic oesophagitis.